The only microfocused ultrasound with real-time visualisation (MFU–V)1-3

PROVEN BY SCIENCE.

MASTERED BY YOU.1,4,5

Innovative non-invasive skin lifting and tightening technology, for visible, reproducible results1,2

Ultherapy® is the Gold Standard non-surgical skin-tightening treatment.
  • A leading non-surgical skin tightening treatment, grounded in clinical evidence with high patient satisfaction1,6,7
  • Advanced micro-focused ultrasound targets deep tissue planes for effective collagen synthesis1,2
  • Real-time visualisation enables you to customise treatment for optimised results1,2
  • The only FDA-cleared skin lifting and tightening device indicated for imaging below the skin’s surface1,3
Ultherapy® is the Gold Standard non-surgical skin-tightening treatment.

DEMAND FOR NON-INVASIVE
SKIN TIGHTENING CONTINUES TO GROW8

There has been a 77% increase in demand for non-surgical skin tightening procedures.
Popularity of non-surgical skin tightening procedures has increased by 77% from 2014 to 2016.9,10

What percentage increase have you seen in your clinic?

050100
50%
SUBMIT

WHY CHOOSE ULTHERAPY®?

Ultherapy® delivers a high level of patient satisfaction.6,7

  • Visible improvements in 3 months7,11
  • A single treatment is usually all that’s needed, for results that can last over a year*1,12,13
  • Minimal downtime after treatment13

Our collagen levels are depleting at a rate of 1% a year from the age of 25, so it comes as no surprise that there is increasing awareness of the benefits of collagen-regenerating treatments such as Ultherapy®, especially among individuals aged 29–45 years, 70% of all Ultherapy® patients. This skin-savvy audience has recognised the benefits of investing in their ‘collagen bank’ for better skin in the longer term and using it as a preventative method.

Dr Tracy Mountford.Founder of The Cosmetic Skin Clinic.
HOW IS ULTHERAPY® DIFFERENT?

 

Offer Ultherapy® in your clinic today–the only authentic micro-focused ultrasound with visualisation skin lifting and tightening device available in the UK and Ireland

*For patients with mild to moderate skin laxity. Individual results may vary

References:

  1. Fabi SG, et alJ Drugs Dermatol. 2019;18(5):426–432.
  2. ULTHERAPY® EU 1001393IFU Rev N IFU, CONTROL UNIT IFU _Final.
  3. Ulthera Press Release: Ultherapy® décolletage treatment now FDA-cleared. BioSpace website. Available at: https://www.biospace.com/article/releases/ulthera-release-ultherapy-and-0174-d%C3%A9colletage-treatment-now-fda-cleared-/ Accessed: July 2021.
  4. White WM, et al. Arch Facial Plast Surg. 2007;9(1):22–29.
  5. Ultherapy®2021 Data on File: Ref-0992.
  6. Ulthera System 501(k) Summary. U.S. Food & Drug Administration website. Available at: www.accessdata.fda.gov/cdrh_docs/pdf13/k134032.pdf Accessed: July 2021.
  7. Werschler WP & Werschler PS. J Clin Aesthet Dermatol. 2016;9(2):27–33.
  8. Ultherapy® 2021 Data on File: Ref-1346.
  9. American Society for Aesthetic Plastic Surgery. 2015 Cosmetic surgery national data bank statistics. Available at: https://www.surgery.org/sites/default/files/ASAPS-Stats2015.pdf Accessed: July 2021.
  10. The American Society for Aesthetic Plastic Surgery. 2016 Cosmetic surgery national data bank statistics. https://www.surgery.org/sites/default/files/ASAPS-Stats2016.pdf Accessed: July 2021.
  11. Kerscher M, et al. Clin Cosmet Investig Dermatol. 2019;12:71–79.
  12. Brobst RW, et al. Facial Plast Surg Clin N Am. 2014;22:191–202.
  13. Sasaki GH & Tevez A. JCDSA. 2012;2:108–116.
CE0344